GALDERMA GROUP AG

Galderma Q3 Surge: Double‑Digit Sales, China Approval & Strong Market Outlook

Galderma’s latest quarterly results show double‑digit sales growth and a new neuromodulator launch in China, reinforcing its leadership in injectable aesthetics.

GALDERMA GROUP AG
Switzerland
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

23/10/2026, 13:36

3 minutes to read

Galderma Surges Past Expectations, Eyes Double‑Digit Growth for 2026

Galderma Group AG’s Q3 earnings beat, double‑digit growth outlook, and strategic arbitration highlight its robust dermatology portfolio and solid upside for investors.

GALDERMA GROUP AG
Switzerland
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

22/10/2026, 19:08

3 minutes to read